Tweet
Cureus
. 2022 Apr 11;14(4):e24049.
doi: 10.7759/cureus.24049. eCollection 2022 Apr.
COVID-19 and Neurologic Manifestations: An Experience at Major New York City Hospitals
Subhadra Nori 1 2 , Alberto Moran 1 , Joseph Franolich 3 , Jasal Patel 4 , Michelle Stern 5
Affiliations
- PMID: 35547415
- PMCID: PMC9090219
- DOI: 10.7759/cureus.24049
Abstract
Introduction: The exact incidence of neurologic manifestations in coronavirus disease 2019 (COVID-19) patients is not clear. The New York City Hospital system has been severely affected by the COVID-19 pandemic between December 2019 and 202. A large number of patients were treated at these centers. This study aims to investigate the incidence of such neurologic manifestations. Secondly, we wanted to find out if there is a correlation between comorbidities and neurologic manifestations in patients with COVID-19.
Methodology: A retrospective analysis of 5,455 Electronic Medical Records of patients with a positive polymerase chain reaction (PCR) result admitted to Elmhurst Hospital, Queens Hospital Center, Jacobi Medical Center, and North Central Bronx Hospitals, four of the 11 teaching hospitals in the NYCHH (New York Health + Hospitals) between 3-1-2020 to 8-31-2020 was carried out. Comprehensive data were collected using medical documentation in five categories: demographic details, comorbidities, symptoms, laboratory findings, and radiologic examinations. All neurologic manifestation keywords were provided to the statisticians by two trained and board-certified physiatrists. Neurologic manifestations were categorized into central nervous system (CNS) manifestations and peripheral nervous system (PNS) manifestations. Results; Out of the 5,455 patients, 285 patients (5.2%) had central nervous system manifestations, a prevalence in people older than 50, and had a high incidence of comorbidities. We found increased D-dimer and high C reactive protein levels. Our findings agree with two of the three authors with significant case volume.
Keywords: anosmia; ataxia; cerebro vascular disease; cognitive dysfunction; covid19; encephalopathy; guillian barre'syndrome; motor weakness; neurological manifestations; seizures.